Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025
Integra LifeSciences Holdings Corporation's (NASDAQ:IART) 25% Dip In Price Shows Sentiment Is Matching Revenues
Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating, Announces Target Price $19
Integra LifeSciences Is Maintained at Hold by Truist Securities
Express News | Integra Lifesciences Holdings Corp : Citigroup Cuts Target Price to $19 From $24
Argus Upgrades Integra LifeSciences to Buy From Hold, Price Target Is $28
Integra LifeSciences Holdings Insiders Placed Bullish Bets Worth US$2.50m
Winners And Losers Of Q4: Integra LifeSciences (NASDAQ:IART) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
INTEGRA STOCKHOLDER NOTICE: Kaskela Law LLC Announces Investigation of Integra LifeSciences Holdings Corp. (IART) and Encourages Long-Term IART Investors to Contact the Firm
Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
Trending Industry Today: Tesla Leads Losses In Brain-Computer Interface Stocks
Integra LifeSciences Reports Mixed Earnings Amid Challenges
Insufficient Growth At Integra LifeSciences Holdings Corporation (NASDAQ:IART) Hampers Share Price
Express News | Citizens Capital Markets Reiterates Market Outperform on Integra Lifesciences, Maintains $35 Price Target
Integra Lifesciences Analyst Ratings
Morgan Stanley Maintains Integra Lifesciences(IART.US) With Sell Rating, Maintains Target Price $20
Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating